AR and prostate carcinoma: For example, MET is highly expressed in AR-negative prostate cancer cell lines such as PC3 and DU145, however, it is downregulated in AR-positive cell lines (LNCaP, LAPC-4, CWR22, and LuCaP) [62,63].